Showing results 21 to 40 of 51
< previous
next >
| Issue Date | Title | Author(s) |
| 2019 | Interferon- salvage treatment is effective for patients with acute leukemia/myelodysplastic syndrome with unsatisfactory response to minimal residual disease-directed donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation | Mo, Xiaodong; Zhang, Xiaohui; Xu, Lanping; Wang, Yu; Yan, Chenhua; Chen, Huan; Chen, Yuhong; Han, Wei; Wang, Fengrong; Wang, Jingzhi; Liu, Kaiyan; Huang, Xiaojun |
| 15-Nov-2022 | Machine Learning Algorithm As a Prognostic Tool for Epstein-Barr Virus Reactivation after Haploidentical Hematopoietic Stem Cell Transplantation | Fan, Shuang; Hong, Hao-Yang; Dong, Xin-Yu; Xu, Lan-Ping; Zhang, Xiao-hui; Wang, Yu; Yan, Chen-Hua; Chen, Huan; Chen, Yu-Hong; Han, Wei; Wang, Fengrong; Wang, Jing-Zhi; Liu, Kaiyan; Shen, Meng-Zhu; Huang, Xiao-jun; Hong, Shen-Da; Mo, Xiao-Dong |
| 2025 | Macrofocal multiple myeloma in the era of novel agents in China | Dou, Xuelin; Liu, Ruixia; Liu, Yang; Peng, Nan; Wen, Lei; Deng, Daoxing; Cao, Leqing; Li, Qian; Wang, Liru; Wang, Fengrong; Mo, Xiaodong; Lu, Jin |
| 5-Nov-2024 | A Matched Comparison of Pola-R-CHP Vs. R-CHOP for DLBCL with Extranodal Involvement | Yang, Shenmiao; Wei, Rong; Liu, Yang; Dou, Xuelin; Wen, Lei; Lu, Jin; Wang, Fengrong; Mo, Xiaodong; Huang, Xiaojun |
| Feb-2024 | Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial | Fu, Haixia; Sun, Xueyan; Lin, Ren; Wang, Yu; Xuan, Li; Yao, Han; Zhang, Yuanyuan; Mo, Xiaodong; Lv, Meng; Zheng, Fengmei; Kong, Jun; Wang, Fengrong; Yan, Chenhua; Han, Tingting; Chen, Huan; Chen, Yao; Tang, Feifei; Sun, Yuqian; Chen, Yuhong; Xu, Lanping; Liu, Kaiyan; Zhang, Xi; Liu, Qifa; Huang, Xiaojun; Zhang, Xiaohui |
| 2019 | Minimal residual disease-directed immunotherapy for high-risk myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation | Mo, Xiaodong; Zhang, Xiaohui; Xu, Lanping; Wang, Yu; Yan, Chenhua; Chen, Huan; Chen, Yuhong; Han, Wei; Wang, Fengrong; Wang, Jingzhi; Liu, Kaiyan; Huang, Xiaojun |
| Oct-2021 | A modified conditioning regimen based on low-dose cyclophosphamide and fludarabine for haploidentical hematopoietic stem cell transplant in severe aplastic anemia patients at risk of severe cardiotoxicity | Lin, Fan; Zhang, Yuanyuan; Han, Tingting; Cheng, Yifei; Mo, Xiaodong; Wang, Jingzhi; Chen, Yuhong; Wang, Fengrong; Tang, Feifei; Han, Wei; Yan, Chenhua; Xu, Zhengli; Zhang, Xiaohui; Wang, Yu; Huang, Xiaojun; Xu, Lanping |
| 15-Jan-2025 | Molecular measurable residual disease before transplantation independently predicts survival and relapse risk in adult lysine methyltransferase 2a-rearranged acute myeloid leukemia | Wang, Lulu; Chen, Yuxiu; Zang, Mengtong; Zhou, Jianying; Xiao, Mengyu; Fu, Haixia; Mo, Xiaodong; Wang, Fengrong; Han, Wei; Zhang, Yuanyuan; Yan, Chenhua; Wang, Zhidong; Han, Tingting; Lv, Meng; Chen, Huan; Chen, Yuhong; Chen, Yao; Wang, Jingzhi; Wang, Yu; Xu, Lanping; Liu, Kaiyan; Huang, Xiaojun; Zhang, Xiaohui |
| 2011 | A Multicenter, Open-Label Study of Posaconazole Oral Suspension in Treatment of Patients with Invasive Fungal Infection Refractory to or Intolerant of First-Line Therapy | Huang, Xiaojun; Wang, Fengrong; Chen, Yuhong; Liu, Ting; Wang, Jianxiang; Hu, Jianda; Jin, Jie; Chen, Fangping; Wang, Shujie; Shen, Zhixiang; Yu, Li; Yu, Kang; Liang, Yingmin |
| 2012 | A multicenter, open-label study of posaconazole oral suspension in the treatment of invasive fungal infections in patients refractory to or intolerant of first-line therapy | Huang, Xiaojun; Wang, Fengrong; Chen, Yuhong; Liu, Ting; Wang, Jianxiang; Hu, Jianda; Jie, Jin; Chen, Fangping; Wang, Shujie; Shen, Zhixiang; Yu, Li; Yu, Kang; Liang, Yingmin |
| 2-Nov-2023 | A Novel Prediction Model for BK Virus Associated Hemorrhagic Cystitis in Acute Leukemia Patients Following Allogenic Hematopoietic Cell Transplantation: A Retrospective Cohort Study | Li, Xueqi; Zhao, Peng; An, Zhuoyu; Fu, Haixia; Zhu, Xiaolu; He, Yun; Wang, Fengrong; Zhang, Yuanyuan; Mo, Xiaodong; Han, Wei; Wang, Jingzhi; Wang, Yu; Chen, Huan; Chen, Yuhong; Zhao, Xiangyu; Xu, Lanping; Liu, Kaiyan; Hua, Yanchen; Kong, Yuan; Chang, Yingjun; Huang, Xiaojun; Zhang, Xiaohui |
| Jan-2021 | Overt gastrointestinal bleeding following haploidentical haematopoietic stem cell transplantation: incidence, outcomes and predictive models | Sun, Xueyan; Su, Yan; Liu, Xiao; Zhang, Yuanyuan; He, Yun; Han, Wei; Chen, Qi; Chen, Huan; Wang, Yu; Cheng, Yifei; Liu, Fengqi; Wang, Fengrong; Chen, Yao; Zhang, Gaochao; Mo, Xiaodong; Fu, Haixia; Chen, Yuhong; Wang, Jingzhi; Zhu, Xiaolu; Xu, Lanping; Liu, Kaiyan; Huang, Xiaojun; Zhang, Xiaohui |
| 15-Nov-2022 | A Phase IV, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) As a Myeloablative Conditioning Regimen in Chinese Multiple Myeloma Patients Undergoing Autologous Stem Cell | Wang, Fengrong; Cai, Zhen; Zou, Dehui; Chen, Wenming; Song, Yongping; Fu, Chengcheng; Hu, Jiong; Yang, Ting; Chen, Xinchuan; Yan, Jinsong; Liu, Kaiyan |
| 23-Nov-2021 | The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation | Gao Mengge; Hong, Yan; Zhao Xiangyu; Sun, Yuqian; Kong, Jun; Wang, Zhidong; Wang, Fengrong; Wang, Jingzhi; Yan, Chenhua; Wang, Yu; Huang, Xiaojun; Zhao, Xiaosu |
| Dec-2022 | Predicting the loss of hepatitis B surface antigen following haematopoietic stem cell transplantation in patients with chronic HBV infection | Sun, Xueyan; Fu, Haixia; Wang, Chencong; Zhang, Yuanyuan; Han, Wei; Chen, Huan; Wang, Yu; Chen, Qi; He, Yun; Huang, Qiusha; Yan, Chenhua; Chen, Yao; Han, Tingting; Lv, Meng; Mo, Xiaodong; Wang, Jingzhi; Wang, Fengrong; Chen, Yuhong; Zhu, Xiaolu; Xu, Lanping; Liu, Kaiyan; Huang, Xiaojun; Zhang, Xiaohui |
| 19-Nov-2020 | Preemptive interferon-alpha treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCT | Liu, Sining; Luo, Xueyi; Zhang, Xiaohui; Xu, Lanping; Wang, Yu; Yan, Chenhua; Chen, Huan; Chen, Yuhong; Han, Wei; Wang, Fengrong; Wang, Jingzhi; Liu, Kaiyan; Huang, Xiaojun; Mo, Xiaodong |
| 2024 | A prognostic score system in adult T-cell acute lymphoblastic leukemia after hematopoietic stem cell transplantation | Xiao, Mengyu; Zhou, Jianying; Zhu, Xiaolu; He, Yun; Wang, Fengrong; Zhang, Yuanyuan; Mo, Xiaodong; Han, Wei; Wang, Jingzhi; Wang, Yu; Chen, Huan; Chen, Yuhong; Zhao, Xiangyu; Chang, Yingjun; Xu, Lanping; Liu, Kaiyan; Huang, Xiaojun; Zhang, Xiaohui |
| 15-Nov-2022 | A Prospective Study of Short-Term Chemotherapy Bridging Allogeneic-SCT in High Risk Peripheral T-Cell Lymphoma | Wang, Fengrong; Yang, Shenmiao; Wang, Yu; Lu, Jin; Liu, Kaiyan; Huang, Xiao-Jun |
| Sep-2020 | Qishen Yiqi dripping pills for chronic ischaemic heart failure: results of the CACT-IHF randomized clinical trial | Mao, Jingyuan; Zhang, Jian; Lam, Carolyn S. P.; Zhu, Mingjun; Yao, Chen; Chen, Shutao; Liu, Zhongyong; Wang, Fengrong; Wang, Yonggang; Dai, Xiaohua; Niu, Tianfu; An, Dongqing; Miao, Yang; Xu, Tao; Dong, Bo; Ma, Xiaofeng; Zhang, Fengru; Wang, Xiaolong; Fan, Ruihong; Zhao, Yingqiang; Jiang, Tiemin; Zhang, Yuhui; Wang, Xianliang; Hou, Yazhu; Zhao, Zhiqiang; Su, Quan; Zhang, Junhua; Wang, Baohe; Zhang, Boli |
| 15-Nov-2022 | Real-World Study of the Use of Iguratimod to Treat Chronic/Refractory ITP | An, Zhuo-Yu; Wu, Ye-Jun; He, Yun; Zhu, Xiaolu; Fu, Haixia; Wang, Fengrong; Mo, Xiao-Dong; Zhang, Yuanyuan; Han, Wei; Chen, Huan; Chen, Yao; Yan, Chenhua; Chen, Yu-Hong; Han, Tingting; Chang, Yingjun; Zhao, Xiangyu; Xu, Lanping; Liu, Kaiyan; Huang, Xiaojun; Zhang, Xiaohui |
